William R. Coward

1.8k total citations
27 papers, 1.4k citations indexed

About

William R. Coward is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Molecular Biology. According to data from OpenAlex, William R. Coward has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 7 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in William R. Coward's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Asthma and respiratory diseases (6 papers) and Pneumonia and Respiratory Infections (3 papers). William R. Coward is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Asthma and respiratory diseases (6 papers) and Pneumonia and Respiratory Infections (3 papers). William R. Coward collaborates with scholars based in United Kingdom, United States and Switzerland. William R. Coward's co-authors include Gísli Jenkins, Gauri Saini, Linhua Pang, Carol Feghali‐Bostwick, C R Hewitt, Alan J. Knox, Martin K. Church, David I. Pritchard, Clair Phillips and Aras Kadioglu and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

William R. Coward

25 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William R. Coward United Kingdom 19 502 472 369 308 217 27 1.4k
Katsuyuki Takeda United States 22 423 0.8× 641 1.4× 282 0.8× 423 1.4× 324 1.5× 56 1.5k
Manohar Yarlagadda United States 9 488 1.0× 534 1.1× 394 1.1× 277 0.9× 207 1.0× 9 1.4k
Ana Lúcia Coelho United States 23 664 1.3× 681 1.4× 621 1.7× 233 0.8× 171 0.8× 44 1.9k
Sabine Charron France 14 491 1.0× 628 1.3× 486 1.3× 177 0.6× 213 1.0× 19 1.5k
Quan Sha United States 16 194 0.4× 666 1.4× 320 0.9× 453 1.5× 155 0.7× 30 1.5k
Andrew C. Melton United States 17 202 0.4× 936 2.0× 435 1.2× 388 1.3× 168 0.8× 30 1.7k
Koa Hosoki United States 20 204 0.4× 284 0.6× 362 1.0× 404 1.3× 109 0.5× 50 1.1k
Ryuta Kamekura Japan 25 151 0.3× 541 1.1× 443 1.2× 305 1.0× 225 1.0× 69 1.6k
Rosa Ten United States 20 212 0.4× 741 1.6× 390 1.1× 295 1.0× 115 0.5× 28 1.5k
Gerhard Dekan Austria 20 314 0.6× 203 0.4× 376 1.0× 234 0.8× 112 0.5× 54 1.2k

Countries citing papers authored by William R. Coward

Since Specialization
Citations

This map shows the geographic impact of William R. Coward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William R. Coward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William R. Coward more than expected).

Fields of papers citing papers by William R. Coward

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William R. Coward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William R. Coward. The network helps show where William R. Coward may publish in the future.

Co-authorship network of co-authors of William R. Coward

This figure shows the co-authorship network connecting the top 25 collaborators of William R. Coward. A scholar is included among the top collaborators of William R. Coward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William R. Coward. William R. Coward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coward, William R., Stephan Brand, Alice Pasini, et al.. (2017). Interplay between EZH2 and G9a Regulates CXCL10 Gene Repression in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 58(4). 449–460. 44 indexed citations
2.
John, Michelle, Jeremy K. Cockcroft, Tricia M. McKeever, et al.. (2015). Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: a randomized controlled trial. International Journal of COPD. 10. 211–211. 21 indexed citations
3.
Neill, Daniel R., William R. Coward, Jenna F. Gritzfeld, et al.. (2014). Density and Duration of Pneumococcal Carriage Is Maintained by Transforming Growth Factor β1 and T Regulatory Cells. American Journal of Respiratory and Critical Care Medicine. 189(10). 1250–1259. 43 indexed citations
4.
Coward, William R., Daniel R. Neill, Hesham A. Malak, et al.. (2014). The Pneumococcal Polysaccharide Capsule and Pneumolysin Differentially Affect CXCL8 and IL-6 Release from Cells of the Upper and Lower Respiratory Tract. PLoS ONE. 9(3). e92355–e92355. 17 indexed citations
5.
Roach, Katy M., S. Mark Duffy, William R. Coward, et al.. (2013). The K+ Channel KCa3.1 as a Novel Target for Idiopathic Pulmonary Fibrosis. PLoS ONE. 8(12). e85244–e85244. 44 indexed citations
6.
Coward, William R., et al.. (2013). Epidermal growth factor receptor (EGFR) activation is required for TGFβ1-induced epithelial-mesenchymal transition (EMT) in idiopathic pulmonary fibrosis (IPF). 42. 4892. 3 indexed citations
7.
Roach, Katy M., William R. Coward, Carol Feghali‐Bostwick, S. Mark Duffy, & Peter Bradding. (2011). T5 The KCa3.1 K+ channel mediates wound healing in human myofibroblasts. Thorax. 66(Suppl 4). A2–A3.
8.
Clifford, Rachel L., William R. Coward, Alan J. Knox, & Alison E. John. (2011). Transcriptional Regulation of Inflammatory Genes Associated with Severe Asthma. Current Pharmaceutical Design. 17(7). 653–666. 7 indexed citations
9.
10.
Krüger, Bernd, Na Yin, Nan Zhang, et al.. (2010). Islet‐expressed TLR2 and TLR4 sense injury and mediate early graft failure after transplantation. European Journal of Immunology. 40(10). 2914–2924. 48 indexed citations
11.
Simms, Rebecca, William R. Coward, Linhua Pang, Alan J. Knox, & Carol Feghali‐Bostwick. (2010). Identification Of The Sources Of Lung Myofibroblasts Using FSP1 And ±-SMA As Markers In Idiopathic Pulmonary Fibrosis. A1117–A1117. 1 indexed citations
12.
Coward, William R., et al.. (2009). Defective Histone Acetylation Is Responsible for the Diminished Expression of Cyclooxygenase 2 in Idiopathic Pulmonary Fibrosis. Molecular and Cellular Biology. 29(15). 4325–4339. 146 indexed citations
13.
Kadioglu, Aras, et al.. (2006). The Cathepsin B Inhibitor, z-FA-FMK, Inhibits Human T Cell Proliferation In Vitro and Modulates Host Response to Pneumococcal Infection In Vivo. The Journal of Immunology. 177(6). 3827–3836. 29 indexed citations
14.
Coward, William R., Ayman Marei, Aili Yang, Mariuca Vasa‐Nicotera, & Sek C. Chow. (2006). Statin-Induced Proinflammatory Response in Mitogen-Activated Peripheral Blood Mononuclear Cells through the Activation of Caspase-1 and IL-18 Secretion in Monocytes. The Journal of Immunology. 176(9). 5284–5292. 67 indexed citations
15.
Coward, William R. & Sek C. Chow. (2006). Effect of atorvastatin on TH1 and TH2 cytokine secreting cells during T cell activation and differentiation. Atherosclerosis. 186(2). 302–309. 22 indexed citations
16.
Coward, William R., Hironori Sagara, Susan J. Wilson, S.T. Holgate, & Martin K. Church. (2004). Allergen activates peripheral blood eosinophil nuclear factor‐κB to generate granulocyte macrophage‐colony stimulating factor, tumour necrosis factor‐α and interleukin‐8. Clinical & Experimental Allergy. 34(7). 1071–1078. 23 indexed citations
17.
Coward, William R., et al.. (2003). Respiratory syncytial virus infection and virus‐induced inflammation are modified by contaminants of indoor air. Immunology. 108(1). 109–115. 18 indexed citations
18.
Coward, William R., Yoshimichi Okayama, Hironori Sagara, et al.. (2002). NF-κB and TNF-α: A Positive Autocrine Loop in Human Lung Mast Cells?. The Journal of Immunology. 169(9). 5287–5293. 110 indexed citations
19.
Reischl, Ilona, William R. Coward, & Martin K. Church. (1999). Molecular consequences of human mast cell activation following immunoglobulin E–high-affinity immunoglobulin E receptor (IgE–FcϵRI) interaction. Biochemical Pharmacology. 58(12). 1841–1850. 43 indexed citations
20.
Zhang, Shaoli, David F. Anderson, Peter Bradding, et al.. (1998). Human mast cells express stem cell factor. The Journal of Pathology. 186(1). 59–66. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katsuyuki Takeda Breakdown of academic impact, for papers by Manohar Yarlagadda Breakdown of academic impact, for papers by Ana Lúcia Coelho Breakdown of academic impact, for papers by Sabine Charron Breakdown of academic impact, for papers by Quan Sha Breakdown of academic impact, for papers by Andrew C. Melton Breakdown of academic impact, for papers by Koa Hosoki Breakdown of academic impact, for papers by Ryuta Kamekura Breakdown of academic impact, for papers by Rosa Ten Breakdown of academic impact, for papers by Gerhard Dekan
Rankless by CCL
2026